2. Advances in pharmacotherapy for COPD.

Area of Science:

• Pulmonology
• Internal Medicine
• Public Health

Background:

• Chronic obstructive pulmonary disease (COPD) is a leading global cause of death and disease burden.
• COPD prevalence and impact are increasing worldwide, yet research investment remains low.
• Recent global and Japanese guidelines aim to improve COPD diagnosis and treatment.

Purpose of the Study:

• To review current pharmacological therapy recommendations for stable COPD.
• To align with recent global and Japanese COPD management guidelines.
• To address the underdiagnosis and undertreatment of COPD.

Main Methods:

• Literature review of global and Japanese COPD guidelines.
• Synthesis of current evidence on pharmacological treatments for stable COPD.
• Analysis of guideline recommendations for managing stable COPD.

Main Results:

• Guidelines provide updated recommendations for stable COPD pharmacological therapy.
• Specific treatments are suggested to manage symptoms and reduce exacerbations.
• Emphasis on individualized treatment approaches based on disease severity.

Conclusions:

• Current guidelines offer a framework for effective COPD management.
• Pharmacological therapies are crucial for improving patient outcomes.
• Adherence to guidelines can mitigate the growing burden of COPD.